股本结构
单位：万股
| 公告日期 | 2026-08-21 | 2026-07-30 | 2026-07-30 | 2026-05-06 | 2026-05-06 | 2026-03-26 |
|---|---|---|---|---|---|---|
| 证券总股本 | 69.48 | 68.27 | 67.30 | 66.77 | 65.60 | 65.55 |
| 普通股本 | 69.48 | 68.27 | 67.30 | 66.77 | 65.60 | 65.55 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-08-20 | 2026-07-28 | 2026-06-30 | 2026-05-01 | 2026-03-31 | 2026-03-24 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-21 | 69.48 | 未披露 | 定期报告 | 2026-08-20 |
| 2026-07-30 | 68.27 | 未披露 | 定期报告 | 2026-07-28 |
| 2026-07-30 | 67.30 | 未披露 |
更多>>
From April 1, 2026 to June 30, 2026
Issuance of common stock from At-the-Market offering (ATM), net of fees
|
2026-06-30 |
| 2026-05-06 | 66.77 | 未披露 | 定期报告 | 2026-05-01 |
| 2026-05-06 | 65.60 | 未披露 | 定期报告 | 2026-03-31 |
| 2026-03-26 | 65.55 | 未披露 | 定期报告 | 2026-03-24 |
| 2026-01-15 | 65.56 | 未披露 |
更多>>
a 1-for-35 reverse stock split of its shares of common stock
|
2026-01-20 |
| 2026-01-15 | 2294.62 | 未披露 | 定期报告 | 2026-01-15 |
| 2025-10-30 | 2021.62 | 未披露 | 定期报告 | 2025-10-17 |
| 2025-10-30 | 2021.60 | 未披露 |
更多>>
From July 1, 2025 to September 30, 2025
Common stock issued for exercise of warrants
|
2025-09-30 |
| 2025-07-31 | 1924.71 | 未披露 | 定期报告 | 2025-07-29 |
| 2025-07-31 | 1924.70 | 未披露 |
更多>>
From April 1, 2025 to June 30, 2025
Common stock issued for exercise of pre-funded warrants
|
2025-06-30 |
| 2025-04-30 | 1753.60 | 未披露 | 定期报告 | 2025-03-31 |
| 2025-03-12 | 1753.59 | 未披露 | 定期报告 | 2025-02-26 |
| 2025-02-28 | 1753.59 | 未披露 | 定期报告 | 2025-02-20 |
| 2025-02-28 | 1753.60 | 未披露 |
更多>>
From January 1, 2024 to December 31, 2024
Common stock and warrants issued in private placement offering
Stock Options exercised
|
2024-12-31 |
| 2024-10-31 | 1753.60 | 未披露 | 定期报告 | 2024-10-28 |
| 2024-09-30 | 1753.59 | 未披露 |
更多>>
Common stock offered 4,206,106 shares by the company
|
2024-09-30 |
| 2024-09-27 | 1332.98 | 未披露 | 定期报告 | 2024-06-30 |
| 2024-05-08 | 1333.00 | 未披露 |
更多>>
From January 1, 2024 to March 31, 2024
Options exercised
|
2024-03-31 |
| 2024-02-29 | 1331.70 | 未披露 |
更多>>
From January 1, 2023 to December 31,2023
Common stock and warrants issued in private placement offering
|
2023-12-31 |
| 2023-10-26 | 1331.70 | 未披露 | 定期报告 | 2023-10-23 |
| 2023-11-03 | 1331.66 | 未披露 | 定期报告 | 2023-10-13 |
| 2023-10-26 | 947.20 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-07-31 | 947.19 | 未披露 | 定期报告 | 2023-06-30 |
| 2023-03-02 | 947.20 | 未披露 |
更多>>
From January 1, 2022 to December 31, 2022
Shared-Based Compensation
|
2022-12-31 |
| 2022-11-01 | 947.19 | 未披露 | 定期报告 | 2022-10-19 |
| 2022-10-27 | 947.20 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Share-Based Compensation
|
2022-09-30 |
| 2022-08-03 | 946.99 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-08-03 | 947.00 | 未披露 | 定期报告 | 2022-06-30 |
| 2022-04-29 | 946.99 | 未披露 | 定期报告 | 2022-04-29 |
| 2022-04-29 | 947.00 | 未披露 | 定期报告 | 2022-03-31 |
| 2022-03-28 | 946.99 | 未披露 |
更多>>
From January 1, 2021 to December 31, 2021
Common stock issued in public offering
Common stock issued for exercise of warrants
Shares issued in satisfaction of trade payable
Common stock issued in At The Market Transactions (ATM)
Common stock issued in registered direct offering
Shared-Based Compensation
|
2021-12-31 |
| 2021-11-12 | 946.83 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Common stock issued in at the market transactions
Common stock issued in registered direct offering
|
2021-09-30 |
| 2021-09-09 | 1122.53 | 未披露 |
更多>>
1.Common Stock offered 781,615 shares
2.The number of shares of Common Stock to be outstanding after this offering is based on 8,684,625 shares of Common Stock outstanding as of the date hereof.
|
2021-09-09 |
| 2021-09-08 | 868.46 | 未披露 | 定期报告 | 2021-09-08 |
| 2021-08-11 | 851.37 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Shares issued in satisfaction of trade payable
|
2021-06-30 |
| 2021-05-12 | 851.37 | 未披露 | 定期报告 | 2021-05-12 |
| 2021-05-12 | 850.79 | 未披露 |
更多>>
From January 1, 2021 to March 31, 2021
Common stock issued in public offering
Common stock issued for exercise of warrants
|
2021-03-31 |
| 2021-03-31 | 850.36 | 未披露 | 定期报告 | 2021-03-25 |
| 2021-02-11 | 773.22 | 未披露 |
更多>>
1.Securities offered by the company: 5,142,856 Units, with each Unit consisting of one (1) Share and a Warrant to purchase one-half (.5) of a share of common stock.
2.The number of shares of common stock to be outstanding after this offering is based on 2,589,352 shares of common stock outstanding as of the date of this prospectus.
|
2021-02-11 |
| 2021-01-28 | 258.94 | 未披露 | 定期报告 | 2021-01-28 |
| 2021-01-28 | 258.94 | 未披露 | 定期报告 | 2021-01-25 |
| 2021-03-31 | 254.15 | 未披露 |
更多>>
from January 1, 2020 to December 31, 2020
Common stock issued in private placement offering
Common stock issued in public offerings
Preferred stock issued in private placement
Preferred stock exchange to common stock
Common stock issued for exercise of warrants
Share-Based Compensation
|
2020-12-31 |
| 2020-12-21 | 252.57 | 未披露 | 定期报告 | 2020-12-16 |
| 2020-12-02 | 223.41 | 未披露 |
更多>>
On November 30, 2020, Hancock Jaffe Laboratories, Inc. (the “Company”) effected a one-for-twenty five (1:25) reverse stock split (the “Reverse Stock Split”) of the shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”). Following the Reverse Stock Split, the number of shares of Common Stock outstanding was reduced from 55,853,569 shares to 2,234,143 shares.
|
2020-11-30 |
| 2020-11-24 | 5585.36 | 未披露 | 定期报告 | 2020-11-24 |
| 2020-11-13 | 4977.54 | 420.54 | 定期报告 | 2020-11-02 |
| 2020-10-09 | 4977.54 | 未披露 |
更多>>
1.Common Stock offered by the company in this offering 9,532,709 shares.
2.The number of shares of Common Stock to be outstanding after this offering is based on 40,242,734 shares of Common Stock outstanding as of the date hereof.
|
2020-10-09 |
| 2020-10-08 | 4022.77 | 未披露 | 定期报告 | 2020-10-07 |
| 2020-11-17 | 4024.27 | 420.54 |
更多>>
From June 30, 2020 to September 30, 2020
Preferred stock issued in private placement
Common stock issued in public offering
Common stock issued for exercise of warrants
|
2020-09-30 |
| 2020-09-17 | 4009.82 | 420.54 | 定期报告 | 2020-09-15 |
| 2020-09-17 | 4009.82 | 未披露 | 定期报告 | 2020-09-14 |
| 2020-08-12 | 3832.43 | 420.54 | 定期报告 | 2020-07-21 |
| 2020-08-14 | 2394.93 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Common stock issued in public offering
|
2020-06-30 |
| 2020-06-03 | 2394.93 | 未披露 |
更多>>
1.Common Stock offered by us in this offering 2,930,402 shares
2.The number of shares of our Common Stock to be outstanding after this offering is based on 21,018,931 shares of our Common Stock outstanding as of the date hereof
|
2020-06-03 |
| 2020-04-28 | 2101.89 | 未披露 |
更多>>
1.Common Stock offered by us in this offering 1,886,793 shares
2.The number of shares of our Common Stock to be outstanding after this offering is based on 19,132,138 shares of our Common Stock outstanding as of the date hereof
|
2020-04-28 |
| 2020-04-07 | 1913.21 | 未披露 | 定期报告 | 2020-04-06 |
| 2020-06-08 | 1923.19 | 未披露 |
更多>>
From January 1, 2020 to March 31, 2020
Common stock issued private placement offering
|
2020-03-31 |
| 2020-03-18 | 1923.19 | 未披露 | 定期报告 | 2020-03-16 |
| 2020-03-18 | 1793.19 | 未披露 |
更多>>
from January 1, 2019 to December 31, 2019
Common stock issued in private placement offering
Common stock issued in public offering
Stock-based compensation:
Common stock issued to consultants/settlement, net
Amortization of stock options and restricted stock units
|
2019-12-31 |
| 2019-08-05 | 1792.21 | 未披露 |
更多>>
from March 31, 2019 to June 30, 2019
Common stock issued private placement offering
Stock-based compensation:
Common stock issued to consultants/settlement, net
|
2019-06-30 |
| 2019-06-14 | 1792.21 | 未披露 | 定期报告 | 2019-06-14 |
| 2019-06-13 | 1430.65 | 未披露 | 定期报告 | 2019-06-13 |
| 2019-06-13 | 1430.65 | 未披露 | 定期报告 | 2019-06-01 |
| 2019-05-09 | 1414.95 | 未披露 | 定期报告 | 2019-05-09 |
| 2019-05-09 | 1415.56 | 未披露 |
更多>>
from January 1, 2019 to March 31, 2019
Common stock issued private placement offering
Stock-based compensation:
Common stock issued to consultants
|
2019-03-31 |
| 2019-03-29 | 1415.90 | 未披露 | 定期报告 | 2019-03-29 |
| 2019-03-29 | 1415.90 | 未披露 | 定期报告 | 2019-03-28 |
| 2019-03-14 | 1416.77 | 未披露 | 定期报告 | 2019-03-13 |
| 2019-03-14 | 1172.26 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Common stock issued in initial public offering
Redeemable convertible preferred stock converted to common stock
Common stock issued in connection with May Bridge Notes
Common stock issued in satisfaction of Advisory Board fees payable
Common stock issued upon conversion of convertible debt and interest
Common stock issued upon conversion of related party convertible debt and interest
Common stock issued upon exchange of related party notes payable and interestCommon stock issued in satisfaction of deferred salary
Common stock issued to consultants
|
2018-12-31 |
| 2018-11-28 | 1171.73 | 未披露 | 定期报告 | 2018-10-22 |
| 2018-08-10 | 1171.73 | 未披露 |
更多>>
from January 1, 2018 to June 30, 2018
Common stock issued in initial public offering
Preferred stock converted to common stock
Common stock issued in connection with May Bridge Notes
Common stock issued in satisfaction of Advisory Board fees payable
Common stock issued upon conversion of convertible debt and interest
Common stock issued upon conversion of related party convertible debt and interest
Common stock issued upon exchange of related party notes payable and interest
Common stock issued in satisfaction of deferred salary
Stock-based compensation:
Common stock granted to consultants
|
2018-06-30 |
| 2018-06-12 | 1150.73 | 未披露 | 定期报告 | 2018-06-12 |
| 2018-06-12 | 1150.73 | 未披露 | 定期报告 | 2018-06-08 |
| 2018-06-01 | 1096.80 | 未披露 |
更多>>
1.Common stock included in the Units offered 1,500,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 9,467,951 shares of common stock outstanding as of March 31, 2018
3.a one-for-two reverse stock split of our common stock effected on December 14, 2017.
|
2018-05-31 |
| 2018-05-22 | 900.77 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-01-26 | 900.11 | 未披露 | 定期报告 | 2018-01-19 |
| 2017-12-14 | 781.73 | 未披露 | 定期报告 | 2017-12-11 |
| 2017-12-05 | 779.53 | 未披露 | 定期报告 | 2017-11-30 |
| 2017-11-06 | 692.84 | 未披露 |
更多>>
The company effect a one-for-two reverse stock split of the common stock
|
2017-11-01 |
| 2018-01-26 | 613.37 | 113.28 |
更多>>
from December 31, 2016 to September 30, 2017
Series B redeemable convertible preferred stock issued
Stock-based compensation:common stock
|
2017-09-30 |
| 2017-09-07 | 1224.70 | 113.28 |
更多>>
from December 31, 2016 to June 30, 2017
Series B redeemable convertible preferred stock issued
|
2017-06-30 |
From April 1, 2026 to June 30, 2026
Issuance of common stock from At-the-Market offering (ATM), net of fees
a 1-for-35 reverse stock split of its shares of common stock
From July 1, 2025 to September 30, 2025
Common stock issued for exercise of warrants
From April 1, 2025 to June 30, 2025
Common stock issued for exercise of pre-funded warrants
From January 1, 2024 to December 31, 2024
Common stock and warrants issued in private placement offering
Stock Options exercised
Common stock offered 4,206,106 shares by the company
From January 1, 2024 to March 31, 2024
Options exercised
From January 1, 2023 to December 31,2023
Common stock and warrants issued in private placement offering
From January 1, 2022 to December 31, 2022
Shared-Based Compensation
From June 30, 2022 to September 30, 2022
Share-Based Compensation
From January 1, 2021 to December 31, 2021
Common stock issued in public offering
Common stock issued for exercise of warrants
Shares issued in satisfaction of trade payable
Common stock issued in At The Market Transactions (ATM)
Common stock issued in registered direct offering
Shared-Based Compensation
From June 30, 2021 to September 30, 2021
Common stock issued in at the market transactions
Common stock issued in registered direct offering
1.Common Stock offered 781,615 shares
2.The number of shares of Common Stock to be outstanding after this offering is based on 8,684,625 shares of Common Stock outstanding as of the date hereof.
From March 31, 2021 to June 30, 2021
Shares issued in satisfaction of trade payable
From January 1, 2021 to March 31, 2021
Common stock issued in public offering
Common stock issued for exercise of warrants
1.Securities offered by the company: 5,142,856 Units, with each Unit consisting of one (1) Share and a Warrant to purchase one-half (.5) of a share of common stock.
2.The number of shares of common stock to be outstanding after this offering is based on 2,589,352 shares of common stock outstanding as of the date of this prospectus.
from January 1, 2020 to December 31, 2020
Common stock issued in private placement offering
Common stock issued in public offerings
Preferred stock issued in private placement
Preferred stock exchange to common stock
Common stock issued for exercise of warrants
Share-Based Compensation
On November 30, 2020, Hancock Jaffe Laboratories, Inc. (the “Company”) effected a one-for-twenty five (1:25) reverse stock split (the “Reverse Stock Split”) of the shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”). Following the Reverse Stock Split, the number of shares of Common Stock outstanding was reduced from 55,853,569 shares to 2,234,143 shares.
1.Common Stock offered by the company in this offering 9,532,709 shares.
2.The number of shares of Common Stock to be outstanding after this offering is based on 40,242,734 shares of Common Stock outstanding as of the date hereof.
From June 30, 2020 to September 30, 2020
Preferred stock issued in private placement
Common stock issued in public offering
Common stock issued for exercise of warrants
From March 31, 2020 to June 30, 2020
Common stock issued in public offering
1.Common Stock offered by us in this offering 2,930,402 shares
2.The number of shares of our Common Stock to be outstanding after this offering is based on 21,018,931 shares of our Common Stock outstanding as of the date hereof
1.Common Stock offered by us in this offering 1,886,793 shares
2.The number of shares of our Common Stock to be outstanding after this offering is based on 19,132,138 shares of our Common Stock outstanding as of the date hereof
From January 1, 2020 to March 31, 2020
Common stock issued private placement offering
from January 1, 2019 to December 31, 2019
Common stock issued in private placement offering
Common stock issued in public offering
Stock-based compensation:
Common stock issued to consultants/settlement, net
Amortization of stock options and restricted stock units
from March 31, 2019 to June 30, 2019
Common stock issued private placement offering
Stock-based compensation:
Common stock issued to consultants/settlement, net
from January 1, 2019 to March 31, 2019
Common stock issued private placement offering
Stock-based compensation:
Common stock issued to consultants
from December 31, 2017 to December 31, 2018
Common stock issued in initial public offering
Redeemable convertible preferred stock converted to common stock
Common stock issued in connection with May Bridge Notes
Common stock issued in satisfaction of Advisory Board fees payable
Common stock issued upon conversion of convertible debt and interest
Common stock issued upon conversion of related party convertible debt and interest
Common stock issued upon exchange of related party notes payable and interestCommon stock issued in satisfaction of deferred salary
Common stock issued to consultants
from January 1, 2018 to June 30, 2018
Common stock issued in initial public offering
Preferred stock converted to common stock
Common stock issued in connection with May Bridge Notes
Common stock issued in satisfaction of Advisory Board fees payable
Common stock issued upon conversion of convertible debt and interest
Common stock issued upon conversion of related party convertible debt and interest
Common stock issued upon exchange of related party notes payable and interest
Common stock issued in satisfaction of deferred salary
Stock-based compensation:
Common stock granted to consultants
1.Common stock included in the Units offered 1,500,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 9,467,951 shares of common stock outstanding as of March 31, 2018
3.a one-for-two reverse stock split of our common stock effected on December 14, 2017.
The company effect a one-for-two reverse stock split of the common stock
from December 31, 2016 to September 30, 2017
Series B redeemable convertible preferred stock issued
Stock-based compensation:common stock
from December 31, 2016 to June 30, 2017
Series B redeemable convertible preferred stock issued